Skip to main content
# Title Department Research Member Research Year
551 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Asmaa Ahmed Mohamed ahmed 2019
552 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2019
553 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2019
554 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
555 Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome. Department of Clinical Pathology Dr. Noha gaber sayed 2019
556 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019
557 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2019
558 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
559 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019
560 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019